Pulse Biosciences reports first use of pulsed-field ablation catheter

Pulse Biosciences (Nasdaq:PLSE) today announced the completion of the first-in-human procedures for its CellFX nsPFA cardiac catheter.

Related Keywords

Prague ,Praha ,Hlavníesto ,Czech Republic ,California ,United States ,New York ,Petr Neuzil ,Kevin Danahy ,Vivek Reddy , ,Mount Sinai Hospital ,Pulse Biosciences ,Pulse Bioscience ,